Dechra Pharmaceuticals Plc (DPH):企業財務及び戦略的SWOT分析

【英語タイトル】Dechra Pharmaceuticals Plc (DPH) - Financial and Strategic SWOT Analysis Review

Single UserUSD300 ⇒換算¥32,700見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥65,400見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD900 ⇒換算¥98,100見積依頼/購入/質問フォーム

Dechra Pharmaceuticals Plc (Dechra) is a healthcare company that develops, manufactures and markets animal healthcare products. The company offers products which include vetoryl, felimazole, thyforon, malaseb, canaural, isaderm, cardisure, comfortan, octacillin, soludox, methoxasol, cyclospray and equipalazone. Its products are used in therapeutic areas such as anaesthesia and analgesia; dermatology, diets and nutrition, endocrinology, exotics, locomotion, metabolics, water medication, and fluid therapy, aomng others. The company sells its products through a network of distributors in the UK and other European and North American countries. Dechra is headquartered in Northwich, the UK.

Dechra Pharmaceuticals Plc Key Recent Developments

Nov 09, 2016: Dechra Pharmaceuticals: Board Appointment
Sep 09, 2016: Dechra receive FDA approval for first US generic entrant antibiotic
Aug 17, 2016: Consort Medical Announces Directorate Change
Aug 17, 2016: Dechra Pharmaceuticals Announces Appointment of Chief Financial Officer

This comprehensive SWOT profile of Dechra Pharmaceuticals Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Dechra Pharmaceuticals Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.


Table of Contents

Section 1 – About the Company

Dechra Pharmaceuticals Plc – Key Information
Dechra Pharmaceuticals Plc – Overview
Dechra Pharmaceuticals Plc – Key Employees
Dechra Pharmaceuticals Plc – Key Employee Biographies
Dechra Pharmaceuticals Plc – Key Operational Heads
Dechra Pharmaceuticals Plc – Major Products and Services
Dechra Pharmaceuticals Plc – History
Dechra Pharmaceuticals Plc – Company Statement
Dechra Pharmaceuticals Plc – Locations And Subsidiaries
Dechra Pharmaceuticals Plc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Dechra Pharmaceuticals Plc – Business Description
Dechra Pharmaceuticals Plc – Corporate Strategy
Dechra Pharmaceuticals Plc – SWOT Analysis
SWOT Analysis – Overview
Dechra Pharmaceuticals Plc – Strengths
Dechra Pharmaceuticals Plc – Weaknesses
Dechra Pharmaceuticals Plc – Opportunities
Dechra Pharmaceuticals Plc – Threats
Dechra Pharmaceuticals Plc – Key Competitors

Section 3 – Company Financial Performance Charts

Dechra Pharmaceuticals Plc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Dechra Pharmaceuticals Plc, Key Information
Dechra Pharmaceuticals Plc, Key Ratios
Dechra Pharmaceuticals Plc, Share Data
Dechra Pharmaceuticals Plc, Major Products and Services
Dechra Pharmaceuticals Plc, History
Dechra Pharmaceuticals Plc, Key Employees
Dechra Pharmaceuticals Plc, Key Employee Biographies
Dechra Pharmaceuticals Plc, Key Operational Heads
Dechra Pharmaceuticals Plc, Other Locations
Dechra Pharmaceuticals Plc, Subsidiaries
Dechra Pharmaceuticals Plc, Key Manufacturing facilities
Dechra Pharmaceuticals Plc, Key Competitors
Dechra Pharmaceuticals Plc, SWOT Analysis
Dechra Pharmaceuticals Plc, Ratios based on current share price
Dechra Pharmaceuticals Plc, Annual Ratios
Dechra Pharmaceuticals Plc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Dechra Pharmaceuticals Plc, Performance Chart
Dechra Pharmaceuticals Plc, Ratio Charts

★調査レポート[Dechra Pharmaceuticals Plc (DPH):企業財務及び戦略的SWOT分析] (コード:GDPH6739FSA)販売に関する免責事項を必ずご確認ください。
★調査レポート[Dechra Pharmaceuticals Plc (DPH):企業財務及び戦略的SWOT分析]についてメールでお問い合わせ